Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guillermo Valenzuela

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Microorganisms|July 30, 2025
Waterborne Transmission Driving the Prevalence of <i>Blastocystis</i> sp. in Los Ríos Region, Southern ChileDaniel Sanhueza Teneo, Cedric B Chesnais, Javiera Manzano, et al.
World Journal of Clinical Oncology|November 16, 2023
Classification of patients with metastatic colorectal cancer into consensus molecular subtypes into real-world: A pilot studyJaime González-Montero, Mauricio Burotto, Guillermo Valenzuela, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 19, 2024
Efficacy and Safety of Intravenous Secukinumab in Patients With Active Axial Spondyloarthritis: Results From a Randomized, Placebo-Controlled, Phase 3 StudyAtul Deodhar, Jerzy Supronik, Alan Kivitz, et al.
Biomolecules|February 27, 2026
A Simplified Strategy for Nanobody Production and Use Based on Functional GST-Nanobody Fusion ProteinsAgustín A Burgos, Andrés Rivera-Dictter, Pablo Mendoza-Soto, et al.
Clinical Pharmacology and Therapeutics|June 2, 2025
Model-Informed Drug Development-Based Bridging from Subcutaneous to Intravenous Secukinumab Dosing: Approval in Psoriatic Arthritis and Axial SpondyloarthritisThomas Dumortier, Guillermo Valenzuela, Melvin Churchill, et al.
British Journal of Clinical Pharmacology|March 31, 2015
Treatment of spontaneous preterm labour with retosiban: a phase 2 proof-of-concept studySteven Thornton, Hugh Miller, Guillermo Valenzuela, et al.
Plos One|September 29, 2017
Human platelet interaction with E. coli O111 promotes tissue-factor-dependent procoagulant activity, involving Toll like receptor 4Valeria Matus, J Guillermo Valenzuela, Patricia Hidalgo, et al.
British Journal of Clinical Pharmacology|May 31, 2017
Treatment of spontaneous preterm labour with retosiban: a phase II pilot dose-ranging studySteven Thornton, Guillermo Valenzuela, Charlotte Baidoo, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 19, 2024
Efficacy and Safety of Intravenous Secukinumab for the Treatment of Active Psoriatic Arthritis: Results From a Randomized, Placebo-Controlled Phase 3 StudyAlan Kivitz, Liliana Sedova, Melvin Churchill, et al.
Annals of the Rheumatic Diseases|May 26, 2026
Effect of apremilast on whole-body magnetic resonance imaging of peripheral and axial inflammation in patients with psoriatic arthritisMikkel Østergaard, Robert G W Lambert, Walter P Maksymowych, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Microorganisms|July 30, 2025
Waterborne Transmission Driving the Prevalence of <i>Blastocystis</i> sp. in Los Ríos Region, Southern ChileDaniel Sanhueza Teneo, Cedric B Chesnais, Javiera Manzano, et al.
World Journal of Clinical Oncology|November 16, 2023
Classification of patients with metastatic colorectal cancer into consensus molecular subtypes into real-world: A pilot studyJaime González-Montero, Mauricio Burotto, Guillermo Valenzuela, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 19, 2024
Efficacy and Safety of Intravenous Secukinumab in Patients With Active Axial Spondyloarthritis: Results From a Randomized, Placebo-Controlled, Phase 3 StudyAtul Deodhar, Jerzy Supronik, Alan Kivitz, et al.
Biomolecules|February 27, 2026
A Simplified Strategy for Nanobody Production and Use Based on Functional GST-Nanobody Fusion ProteinsAgustín A Burgos, Andrés Rivera-Dictter, Pablo Mendoza-Soto, et al.
Clinical Pharmacology and Therapeutics|June 2, 2025
Model-Informed Drug Development-Based Bridging from Subcutaneous to Intravenous Secukinumab Dosing: Approval in Psoriatic Arthritis and Axial SpondyloarthritisThomas Dumortier, Guillermo Valenzuela, Melvin Churchill, et al.
British Journal of Clinical Pharmacology|March 31, 2015
Treatment of spontaneous preterm labour with retosiban: a phase 2 proof-of-concept studySteven Thornton, Hugh Miller, Guillermo Valenzuela, et al.
Plos One|September 29, 2017
Human platelet interaction with E. coli O111 promotes tissue-factor-dependent procoagulant activity, involving Toll like receptor 4Valeria Matus, J Guillermo Valenzuela, Patricia Hidalgo, et al.
British Journal of Clinical Pharmacology|May 31, 2017
Treatment of spontaneous preterm labour with retosiban: a phase II pilot dose-ranging studySteven Thornton, Guillermo Valenzuela, Charlotte Baidoo, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 19, 2024
Efficacy and Safety of Intravenous Secukinumab for the Treatment of Active Psoriatic Arthritis: Results From a Randomized, Placebo-Controlled Phase 3 StudyAlan Kivitz, Liliana Sedova, Melvin Churchill, et al.
Annals of the Rheumatic Diseases|May 26, 2026
Effect of apremilast on whole-body magnetic resonance imaging of peripheral and axial inflammation in patients with psoriatic arthritisMikkel Østergaard, Robert G W Lambert, Walter P Maksymowych, et al.
Pageof 4